Since 2021, Philips has been battling a series of crises over its DreamStation machines for sleep apnea, a disorder in which ...

During its first-quarter earnings report this spring, Philips, the health technology company, announced it agreed to pay $1.1 billion in a settlement over respiration and sleep apnea machines.

The global anti-snoring devices market has experienced significant growth in recent years. Vendors are investing in AI-powered devices that can assess sleep patterns and make real-time adjustments, ...

The global sleep apnea devices market report consists of exclusive data on 39 vendors. The competitive landscape of sleep apnea devices is dynamic, with multiple players vying for market share through ...

Obstructive sleep apnea (OSA) may raise the risk for Parkinson’s disease (PD), but early use of continuous positive airway pressure (CPAP) may mediate that effect, a large observational study ...

This provides a squeeze on two ends for Philips. While Philips has made significant steps in leaving the sleep apnea scandal behind. The company has been sued by investors over the scandal.

Even after becoming aware of it, only 59.5 percent sought medical treatment, while 27.7 percent remained unaware of CPAP therapy. According to Philips Korea, its Sleep and Respiratory Care ...

Three Dutch pension funds have held off from joining a mass compensation claim against Philips over health problems linked to its devices to treat sleep apnoea. The metal and technology sector fund ...

The global home sleep apnea testing market is on a trajectory of steady expansion, with sales projected to grow from an estimated USD 712.3 million in 2025 to USD 966.1 million by 2035. The market is ...

In the year following that investment, Amsterdam-listed shares in Philips jumped almost 50%, also supported by a final deal on its sleep apnea machines reached with the U.S. government last year.